Home / Private raises / Matchpoint Therapeutics Inc.
Matchpoint Therapeutics Inc.
Pharmaceuticals · Watertown, Massachusetts · $68.4M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | D (new) | $68.4M | $150M | 22 | 506(b) | Equity | Oct 1 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Pharmaceuticals |
| Located | Watertown, Massachusetts |
| Entity | Corporation |
| Incorporated | Delaware, 2021 |
| SEC CIK | 1950915 |
People named in the latest filing
| Name | Role |
|---|---|
| Andre Turenne | Executive Officer, Director |
| Brian Matesic | Director |
| Kanishka Pothula | Director |
| Jason Hafler | Director |
| Bruce Booth | Director |
| Daniel Becker | Director |
| Donald Nicolson | Director |
| Jared Cumming | Executive Officer |
| John O'Malley | Executive Officer |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
